Daiichi Sankyo

Enhertu

Manufacturer:

Daiichi Sankyo

Enhertu HCPCS:

J9358

HCPCS Code Descriptor:

Injection, fam-trastuzumab deruxtecan-nxki, 1 mg

Category:

J Code

Enhertu NDCs:

65597-0406-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Enhertu:

Enhertu is an Oncology drug manufactured by Daiichi Sankyo and administered via the Intravenous route of administration. The J Code: J9358 is aligned to the drug Enhertu.

ACCESS PRICING AND MORE BY REGISTERING

J9358 Added Date:

July 1, 2020

J9358 Effective Date:

July 1, 2020

J9358 Termination Date:

HCPCS Active

Enhertu billing and coding information can be found through Daiichi Sankyo at the link below:
Enhertu patient assistance information can be found through AstraZeneca Access 360 at the URL: https://www.myaccess360.com/home.html
Enhertu prescribing information can be found at the link below:
Information regarding Enhertu’s side effects can be found at MedlinePlus